Results 271 to 280 of about 99,201 (311)

Hematologic malignancies and thrombosis

Thrombosis Research, 2012
Patients with hematologic malignancies have an increased risk of venous thromboembolism (VTE), particularly at diagnosis and during the treatment with chemotherapy, asparaginase or immunomodulatory drugs (IMiDs). A disease-dependent hypercoagulable condition associated with other risk factors like drugs, central venous catheter (CVC), immobility and ...
F, Elice, F, Rodeghiero
openaire   +2 more sources

Hematologic manifestations of malignancy

Disease-a-Month, 1989
Hematologic dysfunction occurs commonly in patients with malignancy. Over half are anemic, often because of acute or chronic blood loss, marrow involvement by the malignancy, marrow suppressive effects of chemotherapy or radiation therapy, or because of the anemia of chronic disease.
R A, Johnson, G D, Roodman
openaire   +2 more sources

Mucositis in malignant hematology

Expert Review of Hematology, 2010
Mucosal barrier injury (MBI), also known as mucositis, is the result of the cytotoxic effects of many treatments given for hematological malignancies (HMs) and represents a major source of potentially devastating clinical complications and negative consequences afflicting the patient's management, such as a longer hospitalization, the need of analgesic
openaire   +2 more sources

Hematologic Malignancies Are Associated With Adverse Perioperative Outcomes After Total Hip Arthroplasty

Journal of Arthroplasty, 2017
BACKGROUND: Advancements in treating hematologic malignancies have improved survival, and these patients may be part of the growing population undergoing total hip arthroplasty (THA). Therefore, the purpose of this study was to evaluate the perioperative
Jared M Newman, Jaiben George, Suparna M Navale   +2 more
exaly   +1 more source

MicroRNAs in hematological malignancies

Blood Reviews, 2013
MicroRNAs (miRNAs) have become one of the hottest topics in biology over recent years, but remarkably have only been formally recognized for just over 10 years. These endogenously produced short (19-24 nt) non-coding RNAs have introduced an entirely new paradigm in our understanding of gene control and it is now evident that miRNAs play a crucial ...
openaire   +2 more sources

Hematologic malignancies of the pancreas

Abdominal Imaging, 2014
Hematologic malignancies are relatively uncommon neoplasms of abdominal soft tissue. This article discusses the clinical and imaging features of pancreatic lymphoma, pancreatic extraosseous multiple myeloma, granulocytic sarcoma (chloroma), posttransplant lymphoproliferative disorder, and Castleman disease.
Kumar, Sandrasegaran, Anderanik, Tomasian, Khaled M, Elsayes, Harris, Nageswaran, Akram, Shaaban, Alampady, Shanbhogue, Christine O, Menias   +6 more
openaire   +2 more sources

Genistein and hematological malignancies

Cancer Letters, 2010
Genistein is an isoflavanoid from soybeans and promising cancer chemotherapeutic agent. Genistein exposure varies widely because of cultural differences in diet. Hypothetically, this could account for differential cancer risk across ethnic populations.
Wang, Li, Lynn T, Frame, Samantha, Hirsch, Everardo, Cobos   +3 more
openaire   +2 more sources

Infections in Hematological Malignancies

Disease-a-Month, 2012
nfections in patients suffering from hematological malignancies are a requent problem, leading to higher mortality and morbidity, increased osts of health care, and increased frequency and prolonged duration of ospitalization. Hematological malignancies by themselves or by virtue f their therapeutic strategies, chemotherapy, radiation, or hematopoietic
Walid, Khayr, Rami Y, Haddad, Salman A, Noor   +2 more
openaire   +2 more sources

Hyperamylasemia and Hematologic Malignancies

Annals of Internal Medicine, 1992
Excerpt To the Editors:Hyperamylasemia has been described in association with numerous solid malignant tumors (1, 2), but its association with hematologic malignancies has not been extensively stud...
L, Stein, S, Bank, K, Rai
openaire   +2 more sources

Epigenetics in Hematological Malignancies

2018
Acute leukemias are hematologic malignancies with aggressive behavior especially in adult population. With the introduction of new gene expression and sequencing technologies there have been advances in the knowledge of the genetic landscape of acute leukemias.
Nataly, Cruz-Rodriguez, Alba L, Combita, Jovanny, Zabaleta   +2 more
openaire   +2 more sources